Welcome, Reshma Shetty

This profile has not been claimed and data may not be accurate.

Founder79

48th percentile

Investor36

74th percentile

Combined115
YC S14First-Time FounderUnicorn FounderIPORaised $50M+500+ EmployeesOn Wikipedia

Founder Matrix

Credibility

Technical 34Traction 54Operator 19Domain 41GTM 33
this founder typical founder (50th pct)

Traction · 54th percentile

  • Ginkgo Bioworks raised at least $51.6M per SEC Form D exempt-offering filings naming Reshma Shetty as a related person.
  • Current co-founder of Ginkgo Bioworks, where she has served since 2008.
  • Ginkgo Bioworks went public via IPO in 2021, representing a founder exit.

Founder score

Investor score

What you likely need

Reshma Shetty is a high-credibility deep-tech founder whose company Ginkgo Bioworks has already gone public, giving her a rare combination of YC pedigree, a successful IPO exit, and active VC involvement through Pillar VC. Her primary opportunity now lies in leveraging her public-company founder status and biotech domain expertise to expand her investing platform and thought leadership. Reactivating her technical public presence (GitHub, writing) would strengthen her builder brand in the synthetic biology and bio-AI space.

Are these your current priorities?

We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.

  • positioningPublish a public investment thesis for Pillar VC focused on your biotech and deep-tech expertise to attract deal flow aligned with your domain knowledge.
  • positioningWrite or speak publicly about the intersection of AI and synthetic biology — your Ginkgo Datapoints and Virtual Cell work is cutting-edge and underrepresented in mainstream tech media.
  • tacticalReactivate your GitHub presence by open-sourcing tools or notebooks related to Ginkgo's bio-AI work, which would strengthen your builder credibility in the developer-biology community.
  • introsLeverage your YC S14 alumni status to source and mentor early-stage biotech founders through YC's alumni network, reinforcing your position as a domain-expert investor.
  • positioningPursue independent board director roles at public or late-stage biotech companies — your IPO experience at Ginkgo is a rare and highly valued credential.
  • fundraisingIf Pillar VC is raising a new fund, your Ginkgo IPO track record is a compelling anchor story for LPs evaluating deep-tech seed funds.
  • tacticalPublish Ginkgo Datapoints datasets formally on Hugging Face under your personal account to build a public ML/bio-AI research identity that complements your founder profile.